finanzen.net
19.04.2019 13:00
Bewerten
(0)

Study: Opioid dose variability may be a risk factor for opioid overdose

DRUCKEN

DENVER, April 19, 2019 /PRNewswire/ -- Patients prescribed opioid pain medications whose doses varied over time were 3 times more likely to experience an overdose than patients prescribed stable opioid doses, according to an observational study from Kaiser Permanente published today in JAMA Network Open. The study also showed that patients who discontinued long-term opioid therapy for 3 or more months had half the risk of opioid overdose.

Kaiser Permanente Logo. (PRNewsFoto/Kaiser Permanente) (PRNewsfoto/Kaiser Permanente)

"Our study suggests that safely managing long-term opioid therapy is complex," said Ingrid Binswanger, MD, senior investigator at Kaiser Permanente Institute for Health Research in Colorado and co-author of the study.

"This study suggests going up and down on opioid doses — also called dose variability — could present an increased risk of overdose," Dr. Binswanger said. "Through this study, we also found eventually discontinuing opioid therapy may prevent overdoses. With continued studies, we hope to find out how care providers can help patients with their pain without putting them at unnecessary risk due to rapid changes in their dose."

The 12-year study included more than 14,000 Kaiser Permanente members in Colorado who were prescribed long-term opioids. Researchers used electronic health records to track the history of patients to see if they had dose changes and overdoses from opioid pain medications and other opioid drugs.

The research team obtained a follow-up $2 million, 4-year grant from the National Institutes for Health. The study will look at how patients and doctors manage changes in opioid doses, including any long-term risks and benefits of discontinuing opioid pain medications.

"Kaiser Permanente, like many health care organizations across the country, has made significant changes to safely reduce opioid prescriptions for our members," said Jason Glanz, PhD, senior investigator at the Institute for Health Research and co-author on the study.

"This study represents the first of many investigations that we plan to do on the topic," Dr. Glanz said. "Our goal is to help identify the most safe and effective approaches for managing long-term opioid therapy. We want to be able to minimize patients' pain and reduce their risk for overdose."

This study was funded by the National Institute on Drug Abuse and conducted by researchers at Kaiser Permanente's Institute for Health Research.

Additional study authors include Susan Shetterly, MS; Komal J. Narwaney, MPH, PhD; and Stan Xu, PhD.

About Kaiser Permanente
Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, Kaiser Permanente has a mission to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve more than 12.4 million members in 8 states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal Permanente Medical Group physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to kp.org/share

Media Contact:
Nick Roper 303-905-7451 Nicholas.Mark.Roper@kp.org
Heather Platisha 415-676-8030 hplatisha@webershandwick.com 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/study-opioid-dose-variability-may-be-a-risk-factor-for-opioid-overdose-300834286.html

SOURCE Kaiser Permanente

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX geht über 12.000 Punkten ins Wochenende -- US-Börsen schließen im Plus -- May kündigt Rücktritt an -- VW stellt sich auf Mammutverfahren ein -- adidas, OSRAM, Vapiano im Fokus

Boeing muss 737 Max auf Werksgeländen parken. Trump-Familie geht im Streit um Bankunterlagen in Berufung. Deutsche Börse-Aktie nach Investorentag an DAX-Spitze. Auch Siemens prüft Geschäftsbeziehungen zu Huawei. SMA Solar-Aktie mit Kurssprung. Facebook entfernt mehr als drei Milliarden Fake-Konten.

Die 5 beliebtesten Top-Rankings

Das hat sich geändert
Diese Aktien hat George Soros im Depot
Big-Mac-Index
In welchen Ländern kostet der Big Mac wie viel?
Das verdienen Aufsichtsratschefs in DAX-Konzernen
Deutlich unter Vorstandsgehältern
Apps & Social Media: Die wertvollsten Marken der Welt
Welche Marke macht das Rennen?
Die Länder mit den größten Goldreserven 2019
Wer lagert das meiste Gold?
mehr Top Rankings

Umfrage

Die rechtspopulistische FPÖ in Österreich hat für einen Skandal gesorgt. Wie glauben Sie wird sich das auf die Europawahlen auswirken?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Deutsche Bank AG514000
CommerzbankCBK100
Wirecard AG747206
Daimler AG710000
Scout24 AGA12DM8
TeslaA1CX3T
Apple Inc.865985
Amazon906866
Huawei TechnologiesHWEI11
Allianz840400
BMW AG519000
BASFBASF11
NEL ASAA0B733
BayerBAY001
E.ON SEENAG99